Compound information
- Natural Products
- ZC1870807
- Molecular Formula
- C21H24N2O3
- Molecular Weight
- 352.178692628 g/mol
- Structure
-
- IUPAC Name
- benzyl (2S)-2-(2-phenylethylcarbamoyl)pyrrolidine-1-carboxylate
- InChI
- InChI=1S/C21H24N2O3/c24-20(22-14-13-17-8-3-1-4-9-17)19-12-7-15-23(19)21(25)26-16-18-10-5-2-6-11-18/h1-6,8-11,19H,7,12-16H2,(H,22,24)/t19-/m0/s1
- InChI Key
- YDUUUFDZIBNORX-IBGZPJMESA-N
- SMILES
- O=C(NCCc1ccccc1)[C@@H]1CCCN1C(=O)OCc1ccccc1
- Source
- ZINC000096783007
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 3 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 58.64 Å2 | LogP | 3.471 |
LogS | -3.822 | LogD | 3.64 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.973 | Pgp substrate | 0.01 |
HIA | 0.97 | F20 % | 0.993 |
F30 % | 0.13 | Caco-2 | -4.422 |
MDCK | -4.713 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.004 | PPB | 94.386 |
VD | 2.05 | Fu | 1.385 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.352 | CYP1A2 substrate | 0.733 |
CYP2A6 substrate | 0.565 | CYP2B6 substrate | 0.674 |
CYP2C19 inhibitor | 0.843 | CYP2C19 substrate | 0.89 |
CYP2C8 substrate | 0.807 | CYP2C9 inhibitor | 0.89 |
CYP2C9 substrate | 0.947 | CYP2D6 inhibitor | 0.724 |
CYP2D6 substrate | 0.979 | CYP2E1 substrate | 0.187 |
CYP3A4 inhibitor | 0.39 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.54 | CL | 7.242 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.903 | Hepatotoxicity | 0.436 |
Mutagenicity | 0.002 | Rat Oral Acute Toxicity | 0.55 |
FDAMDD | 0.714 | Skin Sensitization | 0.309 |
Carcinogenicity | 0.038 | Eye Corrosion | 0.002 |
Eye Irritation | 0.017 | Respiratory Toxicity | 0.134 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.643 | IGC50 | 3.899 |
LC50FM | 2.592 | LC50DM | 2.188 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.372 | NR-AR-LBD | 0.159 |
NR-AhR | 0.015 | NR-Aromatase | 0.032 |
NR-ER | 0.326 | NR-ER-LBD | 0.462 |
NR-PPAR-gamma | 0.236 | SR-ARE | 0.211 |
SR-ATAD5 | 0.378 | SR-HSE | 0.284 |
SR-MMP | 0.171 | SR-p53 | 0.022 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.